Kansas SB 212: Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

Status: Died in Committee (as of 2026-04-10)

State: Kansas · Session: 2025-2026 · Bill: SB 212

Subjects: Insurance, Named Acts, Pharmacists and Pharmacy

Sponsors: Dinah Sykes

View Kansas SB 212 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.